MURPHY ANDREW J (EVP Research) exercised options at REGENERON PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 10/31/2025ACC: 0001796226-25-000005
Officer· EVP Research
Since Dec 2019
-34.03K
Net shares
Net seller
$21.08M
Total sold
0
Open market trades
0B · 0S
4
Total transactions
35K acquired · 69.03K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+35K
Price / share
$555.67
Trade value
$19.45M
% of position
71.3%
10/29/2025
49.07K→84.07K
Common Stock
Direct
Shares
−32.49K
Price / share
$648.82
Trade value
$21.08M
% of position
38.6%
10/29/2025
84.07K→51.58K
Common Stock
Direct
Shares
−1.54K
Price / share
—
Trade value
—
% of position
3.0%
10/30/2025
51.58K→50.05K
Total
Net shares
+972.00
Net value
-$1.63M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/29/2025 | M · Option Exercise | +35K | $555.67 | $19.45M | 71.3% | 49.07K | 84.07K |
| Common Stock Direct | 10/29/2025 | F · Tax Withholding | −32.49K | $648.82 | $21.08M | 38.6% | 84.07K | 51.58K |
| Common Stock Direct | 10/30/2025 | G · Gift | −1.54K | — | — | 3.0% | 51.58K | 50.05K |
| Total | +972.00 | -$1.63M | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
35K shares
Shares
−35K
Strike price
555.67
Held after
0.00
Exercisable
—
10/29/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock35K shares | 10/29/2025 | M · Option Exercise | −35K | 555.67 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.37K
Total
4.37K indirect4.37K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.37K | Indirect |
| Total | 4.37K | 4.37K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported